$PDLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDL BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PDL BIOPHARMA, INC.. Get notifications about new insider transactions in PDL BIOPHARMA, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 11 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 23.89 | 15,000 | 358,350 | 15,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Chairman of the Boa ... | Option Exercise | A | 23.89 | 5,000 | 119,450 | 5,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Chairman of the Boa ... | Option Exercise | A | 23.89 | 15,000 | 358,350 | 15,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Chairman of the Boa ... | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Chairman of the Boa ... | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Chairman of the Boa ... | Option Exercise | A | 23.89 | 4,167 | 99,550 | 4,167 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 23.89 | 5,000 | 119,450 | 5,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 23.89 | 15,000 | 358,350 | 15,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | A | 23.89 | 5,000 | 119,450 | 5,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | A | 23.89 | 15,000 | 358,350 | 15,000 | |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 645 | 11,049 | 23,905 | |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.55 | 65 | 1,596 | 0 | 65 to 0 (-100.00 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.53 | 65 | 1,594 | 65 | 130 to 65 (-50.00 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.50 | 65 | 1,593 | 130 | 195 to 130 (-33.33 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.48 | 65 | 1,591 | 195 | 260 to 195 (-25.00 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.43 | 65 | 1,588 | 260 | 325 to 260 (-20.00 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.36 | 65 | 1,583 | 325 | 390 to 325 (-16.67 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.33 | 65 | 1,581 | 390 | 455 to 390 (-14.29 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.32 | 65 | 1,581 | 455 | 520 to 455 (-12.50 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.30 | 65 | 1,580 | 520 | 585 to 520 (-11.11 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.35 | 60 | 1,461 | 585 | 645 to 585 (-9.30 %) |
| Jun 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 645 | 11,049 | 645 | 0 to 645 |
| Jun 21 2007 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 23.89 | 5,000 | 119,450 | 5,000 | |
| Jun 21 2007 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 23.89 | 15,000 | 358,350 | 15,000 | |
| Jun 21 2007 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 23.89 | 500 | 11,945 | 500 | |
| Jun 21 2007 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 23.89 | 1,000 | 23,890 | 1,000 | |
| May 30 2007 | PDLI | PDL BIOPHARMA, INC ... | GUGGENHIME ANDREW | SVP & Chief Financ ... | Payment of Exercise | F | 21.80 | 670 | 14,606 | 6,830 | 7.5 K to 6.8 K (-8.93 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 48,132 | |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.81 | 225 | 6,032 | 0 | 225 to 0 (-100.00 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 27.43 | 218 | 5,980 | 225 | 443 to 225 (-49.21 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 27.32 | 218 | 5,956 | 443 | 661 to 443 (-32.98 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 27.30 | 218 | 5,951 | 661 | 879 to 661 (-24.80 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.88 | 218 | 5,860 | 879 | 1.1 K to 879 (-19.87 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.85 | 218 | 5,853 | 1,097 | 1.3 K to 1.1 K (-16.58 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.80 | 218 | 5,842 | 1,315 | 1.5 K to 1.3 K (-14.22 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 27.00 | 118 | 3,186 | 1,533 | 1.7 K to 1.5 K (-7.15 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.92 | 118 | 3,177 | 1,651 | 1.8 K to 1.7 K (-6.67 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.83 | 118 | 3,166 | 1,769 | 1.9 K to 1.8 K (-6.25 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 27.00 | 100 | 2,700 | 1,887 | 2 K to 1.9 K (-5.03 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.92 | 100 | 2,692 | 1,987 | 2.1 K to 2 K (-4.79 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.82 | 100 | 2,682 | 2,087 | 2.2 K to 2.1 K (-4.57 %) |
| May 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
| May 24 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 21.73 | 1,770 | 38,462 | 5,314 | |
| May 24 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 27.50 | 1,770 | 48,675 | 0 | 1.8 K to 0 (-100.00 %) |
| May 24 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 21.73 | 1,770 | 38,462 | 1,770 | 0 to 1.8 K |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 645 | 11,049 | 24,550 | |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.40 | 65 | 1,716 | 0 | 65 to 0 (-100.00 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.14 | 65 | 1,699 | 65 | 130 to 65 (-50.00 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.58 | 65 | 1,728 | 130 | 195 to 130 (-33.33 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.56 | 65 | 1,661 | 195 | 260 to 195 (-25.00 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.40 | 65 | 1,716 | 260 | 325 to 260 (-20.00 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.25 | 64 | 1,680 | 325 | 389 to 325 (-16.45 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.66 | 64 | 1,706 | 389 | 453 to 389 (-14.13 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.63 | 64 | 1,704 | 453 | 517 to 453 (-12.38 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.59 | 64 | 1,638 | 517 | 581 to 517 (-11.02 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.54 | 64 | 1,699 | 581 | 645 to 581 (-9.92 %) |
| May 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 645 | 11,049 | 645 | 0 to 645 |
| May 14 2007 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Director | Option Exercise | A | 25.51 | 25,000 | 637,750 | 25,000 | |
| May 14 2007 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 25.51 | 3,000 | 76,530 | 3,000 | |
| May 14 2007 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 25.51 | 3,000 | 76,530 | 3,000 | |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 17.13 | 2,397 | 41,061 | 16,353 | |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 15.25 | 13,523 | 206,226 | 5,063 | |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 13.96 | 104 | 1,452 | 313 | |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 9.00 | 156 | 1,404 | 469 | |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 8.55 | 156 | 1,334 | 469 | |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 7.83 | 104 | 814 | 313 | |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 26.00 | 2,397 | 62,322 | 13,940 | 16.3 K to 13.9 K (-14.67 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 17.13 | 2,397 | 41,061 | 16,337 | 13.9 K to 16.3 K (+17.20 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 26.00 | 13,523 | 351,598 | 13,940 | 27.5 K to 13.9 K (-49.24 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 15.25 | 13,523 | 206,226 | 27,463 | 13.9 K to 27.5 K (+97.01 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 26.00 | 104 | 2,704 | 13,940 | 14 K to 13.9 K (-0.74 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 13.96 | 104 | 1,452 | 14,044 | 13.9 K to 14 K (+0.75 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 26.00 | 156 | 4,056 | 13,940 | 14.1 K to 13.9 K (-1.11 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 9.00 | 156 | 1,404 | 14,096 | 13.9 K to 14.1 K (+1.12 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 26.00 | 156 | 4,056 | 13,940 | 14.1 K to 13.9 K (-1.11 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 8.55 | 156 | 1,334 | 14,096 | 13.9 K to 14.1 K (+1.12 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 26.00 | 104 | 2,704 | 13,940 | 14 K to 13.9 K (-0.74 %) |
| Apr 30 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 7.83 | 104 | 814 | 14,044 | 13.9 K to 14 K (+0.75 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 50,319 | |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.39 | 319 | 8,099 | 0 | 319 to 0 (-100.00 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.23 | 219 | 5,525 | 319 | 538 to 319 (-40.71 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.02 | 219 | 5,479 | 538 | 757 to 538 (-28.93 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.47 | 219 | 5,578 | 757 | 976 to 757 (-22.44 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.40 | 219 | 5,563 | 976 | 1.2 K to 976 (-18.33 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.06 | 219 | 5,488 | 1,195 | 1.4 K to 1.2 K (-15.49 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.54 | 119 | 3,039 | 1,414 | 1.5 K to 1.4 K (-7.76 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.49 | 119 | 3,034 | 1,533 | 1.7 K to 1.5 K (-7.20 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.39 | 118 | 2,996 | 1,652 | 1.8 K to 1.7 K (-6.67 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.19 | 117 | 2,947 | 1,770 | 1.9 K to 1.8 K (-6.20 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.54 | 100 | 2,554 | 1,887 | 2 K to 1.9 K (-5.03 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.49 | 100 | 2,549 | 1,987 | 2.1 K to 2 K (-4.79 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.21 | 100 | 2,521 | 2,087 | 2.2 K to 2.1 K (-4.57 %) |
| Apr 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 645 | 11,049 | 25,195 | |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 24.16 | 64 | 1,546 | 0 | 64 to 0 (-100.00 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.95 | 64 | 1,533 | 64 | 128 to 64 (-50.00 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.94 | 64 | 1,532 | 128 | 192 to 128 (-33.33 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.87 | 64 | 1,528 | 192 | 256 to 192 (-25.00 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.82 | 64 | 1,524 | 256 | 320 to 256 (-20.00 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.76 | 64 | 1,521 | 320 | 384 to 320 (-16.67 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.98 | 133 | 3,189 | 384 | 517 to 384 (-25.73 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.88 | 64 | 1,528 | 517 | 581 to 517 (-11.02 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.87 | 64 | 1,528 | 581 | 645 to 581 (-9.92 %) |
| Apr 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 645 | 11,049 | 645 | 0 to 645 |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 15.25 | 8,414 | 128,314 | 18,586 | |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 13.96 | 3,333 | 46,529 | 417 | |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 12.29 | 3,253 | 39,979 | 0 | |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 25.00 | 8,414 | 210,350 | 13,940 | 22.4 K to 13.9 K (-37.64 %) |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 15.25 | 8,414 | 128,314 | 22,354 | 13.9 K to 22.4 K (+60.36 %) |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 25.00 | 3,333 | 83,325 | 13,940 | 17.3 K to 13.9 K (-19.30 %) |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 13.96 | 3,333 | 46,529 | 17,273 | 13.9 K to 17.3 K (+23.91 %) |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 25.00 | 3,253 | 81,325 | 13,940 | 17.2 K to 13.9 K (-18.92 %) |
| Apr 24 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 12.29 | 3,253 | 39,979 | 17,193 | 13.9 K to 17.2 K (+23.34 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Corporate Servi ... | Option Exercise | M | 13.29 | 10,935 | 145,326 | 19,690 | |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Corporate Servi ... | Sell | S | 24.26 | 4,373 | 106,089 | 24,382 | 28.8 K to 24.4 K (-15.21 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Corporate Servi ... | Sell | S | 23.69 | 4,375 | 103,644 | 28,755 | 33.1 K to 28.8 K (-13.21 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Corporate Servi ... | Sell | S | 23.72 | 2,187 | 51,876 | 33,130 | 35.3 K to 33.1 K (-6.19 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Corporate Servi ... | Buy | M | 13.29 | 10,935 | 145,326 | 35,317 | 24.4 K to 35.3 K (+44.85 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 12.29 | 1,747 | 21,471 | 3,253 | |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 9.00 | 6,875 | 61,875 | 625 | |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 8.55 | 1,378 | 11,782 | 625 | |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 8.55 | 5,497 | 46,999 | 2,003 | |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Option Exercise | M | 7.83 | 4,583 | 35,885 | 417 | |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 24.00 | 1,747 | 41,928 | 13,940 | 15.7 K to 13.9 K (-11.14 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 12.29 | 1,747 | 21,471 | 15,687 | 13.9 K to 15.7 K (+12.53 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 24.00 | 6,875 | 165,000 | 13,940 | 20.8 K to 13.9 K (-33.03 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 9.00 | 6,875 | 61,875 | 20,815 | 13.9 K to 20.8 K (+49.32 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 24.00 | 1,378 | 33,072 | 13,940 | 15.3 K to 13.9 K (-9.00 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 8.55 | 1,378 | 11,782 | 15,318 | 13.9 K to 15.3 K (+9.89 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 23.00 | 5,497 | 126,431 | 13,940 | 19.4 K to 13.9 K (-28.28 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 8.55 | 5,497 | 46,999 | 19,437 | 13.9 K to 19.4 K (+39.43 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Sell | S | 23.00 | 4,583 | 105,409 | 13,940 | 18.5 K to 13.9 K (-24.74 %) |
| Apr 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SR VP, Mkt & Busin ... | Buy | M | 7.83 | 4,583 | 35,885 | 18,523 | 13.9 K to 18.5 K (+32.88 %) |
| Apr 03 2007 | PDLI | PDL BIOPHARMA, INC ... | Savel Robert Michael II | SVP Technical Opera ... | Option Exercise | A | 21.70 | 65,000 | 1,410,500 | 65,000 | |
| Mar 29 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 1,935 | 33,147 | 25,840 | |
| Mar 29 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.00 | 1,935 | 42,570 | 0 | 1.9 K to 0 (-100.00 %) |
| Mar 29 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 1,935 | 33,147 | 1,935 | 0 to 1.9 K |
| Feb 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 54,693 | |
| Feb 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.00 | 2,187 | 43,740 | 0 | 2.2 K to 0 (-100.00 %) |
| Feb 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
| Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 52,506 | |
| Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.71 | 218 | 4,515 | 0 | 218 to 0 (-100.00 %) |
| Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.34 | 219 | 4,454 | 218 | 437 to 218 (-50.11 %) |
| Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.29 | 437 | 8,867 | 437 | 874 to 437 (-50.00 %) |